Covaxin
Earlier this month, a study by a team at Banaras Hindu University (BHU) in Varanasi concluded that fully 1% of Covaxin recipients may suffer severe adverse events. One percent is a large number because the multiplier (x in 1/100 * x) is very large — several million people. The study first
AltBalaji
Vivek Agnihotri’s next film, The Vaccine War, is set to be released on September 28. It is purportedly about the making of Covaxin, the COVID-19 vaccine made by Bharat Biotech, and claims to be based on real events. Based on watching the film’s trailer and snippets shared on
Balram Bhargava
That the Union government and the Indian Space Research Organisation (ISRO) had entered into a more intimate, but not necessarily more beneficial, relationship became evident in 2019 when then ISRO chairman K. Sivan trotted out a series of dubious claims to massage the fate of the Chandrayaan 2 mission, whose
Balram Bhargava
In a new investigation, STAT has reported fresh problems with Covaxin’s approval process in India, including the phase 2 trial dropping its placebo arm in favour of one preordained to make Covaxin look good and Bharat Biotech – the maker – commencing phase 3 trials based on results from animal studies.
Bharat Biotech
If I had been Bharat Biotech’s teacher and “Where is your data?” had been an examination question, Bharat Biotech would have received 1 out of 10 marks. We are proud to #announce our 9th publication today! 12 MONTHS – 9 PUBLICATIONS. Our humble response to “Where is your #data?”… Our
anti-patterns
The last two episodes of the second season of House, the TV series starring Hugh Laurie as a misanthropic doctor at a facility in Princeton, have been playing on my mind off and on during the COVID-19 pandemic. One of its principal points (insofar as Dr Gregory House can admit
Covaxin
The following article has been published in The Wire, but since it began as a blog post and because I haven’t published anything else in a while, I’m using it here as well. The Parliamentary Standing Committee on S&T, Forests and Climate Change has submitted its
Central Drug Standards Control Organisation
By Mukunth and Madhusudhan Raman Former Union health secretary K. Sujatha Rao had a great piece in The Indian Express on January 14, whose takeaway she summarised in the following line: Science, evidence and data analytics need to be the bedrock of the roll-out policy, not politics and scoring brownie
Bharat Biotech
If you’re looking for a quantification (although you shouldn’t) of the extent to which science is being conducted by press releases in India at the moment, consider the following list of studies. The papers for none of them have been published – as preprints or ‘post-prints’ – even as the
